Literature DB >> 7696109

Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy. Italian HUS Study Group.

A Gianviti1, F Rosmini, A Caprioli, R Corona, M C Matteucci, F Principato, I Luzzi, G Rizzoni.   

Abstract

Seventy-six cases of haemolytic-uraemic syndrome (HUS) were collected over a 4-year period during a surveillance and case-control study. The annual incidence of 0.2 per 100,000 children aged 0-14 years is lower than in other countries; 34% had no prodromal diarrhoea. Evidence for verocytotoxin-producing Escherichia coli (VTEC) infection was found in 72% of patients and 3% of controls; 88% of patients with bloody diarrhoea, 67% with non-bloody diarrhoea and 55% without diarrhoea were VTEC positive. Seventy-three percent of patients had creatinine clearance > or = 80 ml/min per 1.73 m2, normal blood pressure, no proteinuria and haematuria < 2+ after 1 year of follow-up. One patient died and none had non-renal sequelae. VTEC positivity was significantly correlated with a good outcome, while the absence of diarrhoea and a high total white blood cell count at onset were not predictors of a bad outcome. Household contacts of HUS patients had diarrhoea more frequently than those of the control group, supporting the hypothesis of person-to-person transmission of VTEC infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696109     DOI: 10.1007/bf00869095

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

1.  Serological identification of Escherichia coli O157 as cause of haemolytic uraemic syndrome in Netherlands.

Authors:  H Chart; B Rowe; N vd Kar; L A Monnens
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

Review 2.  The hemolytic uremic syndrome of childhood and its variants.

Authors:  B S Kaplan; W Proesmans
Journal:  Semin Hematol       Date:  1987-07       Impact factor: 3.851

3.  Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

Authors:  H Kleanthous; H R Smith; S M Scotland; R J Gross; B Rowe; C M Taylor; D V Milford
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

4.  Isolation in Italy of a verotoxin-producing strain of Escherichia coli O157:H7 from a child with hemolytic-uraemic syndrome.

Authors:  A Caprioli; A Edefonti; M Bacchini; I Luzzi; F Rosmini; A Gianviti; M C Matteucci; P Pasquini
Journal:  Eur J Epidemiol       Date:  1990-03       Impact factor: 8.082

5.  Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group.

Authors:  A Caprioli; I Luzzi; F Rosmini; P Pasquini; R Cirrincione; A Gianviti; M C Matteucci; G Rizzoni
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

6.  Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features.

Authors:  C Loirat; E Sonsino; A Varga Moreno; G Pillion; J C Mercier; F Beaufils; H Mathieu
Journal:  Acta Paediatr Scand       Date:  1984-07

7.  Changes in the postenteropathic form of the hemolytic uremic syndrome in children.

Authors:  N A Coad; T Marshall; B Rowe; C M Taylor
Journal:  Clin Nephrol       Date:  1991-01       Impact factor: 0.975

8.  Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome.

Authors:  W L Robson; A K Leung; G H Fick; A I McKenna
Journal:  Nephron       Date:  1992       Impact factor: 2.847

9.  Epidemic Escherichia coli O157:H7 gastroenteritis and hemolytic-uremic syndrome in a Canadian inuit community: intestinal illness in family members as a risk factor.

Authors:  P C Rowe; E Orrbine; M Ogborn; G A Wells; W Winther; H Lior; D Manuel; P N McLaine
Journal:  J Pediatr       Date:  1994-01       Impact factor: 4.406

10.  Haemolytic-uraemic syndrome: an analysis of prognostic features.

Authors:  R S Trompeter; R Schwartz; C Chantler; M J Dillon; G B Haycock; R Kay; T M Barratt
Journal:  Arch Dis Child       Date:  1983-02       Impact factor: 3.791

View more
  10 in total

1.  Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins.

Authors:  Hong-Ying Fan; Ling Wang; Jun Luo; Bei-Guo Long
Journal:  Mol Biol Rep       Date:  2011-05-13       Impact factor: 2.316

2.  Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome.

Authors:  Gianluigi Ardissino; Valeria Daccò; Sara Testa; Cristina Felice Civitillo; Francesca Tel; Ilaria Possenti; Mirco Belingheri; Pierangela Castorina; Nicolò Bolsa-Ghiringhelli; Silvana Tedeschi; Fabio Paglialonga; Stefania Salardi; Dario Consonni; Elena Zoia; Patrizia Salice; Giovanna Chidini
Journal:  Pediatr Nephrol       Date:  2014-08-23       Impact factor: 3.714

Review 3.  Heterogeneity of atypical haemolytic uraemic syndromes.

Authors:  T J Neuhaus; S Calonder; E P Leumann
Journal:  Arch Dis Child       Date:  1997-06       Impact factor: 3.791

4.  Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells.

Authors:  Paola Marcato; George Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

5.  Risk factors for poor renal prognosis in children with hemolytic uremic syndrome.

Authors:  Alessandra Gianviti; Alberto E Tozzi; Laura De Petris; Alfredo Caprioli; Lucilla Ravà; Alberto Edefonti; Gianluigi Ardissino; Giovanni Montini; Graziella Zacchello; Alfonso Ferretti; Carmine Pecoraro; Tommaso De Palo; Angela Caringella; Maurizio Gaido; Rosanna Coppo; Francesco Perfumo; Nunzia Miglietti; Ilse Ratsche; Rosa Penza; Giovambattista Capasso; Silvio Maringhini; Salvatore Li Volti; Carmen Setzu; Marco Pennesi; Alberto Bettinelli; Leopoldo Peratoner; Ivana Pela; Elio Salvaggio; Giuliana Lama; Salvatore Maffei; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

6.  Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network.

Authors:  Gianluigi Ardissino; Stefania Salardi; Elisa Colombo; Sara Testa; Nicolò Borsa-Ghiringhelli; Fabio Paglialonga; Valentina Paracchini; Francesca Tel; Ilaria Possenti; Mirco Belingheri; Cristina Felice Civitillo; Stefano Sardini; Rossella Ceruti; Carlo Baldioli; Paola Tommasi; Luciana Parola; Fiorella Russo; Silvana Tedeschi
Journal:  Eur J Pediatr       Date:  2015-10-24       Impact factor: 3.183

7.  Drug-induced Thrombotic Microangiopathy Caused by Gemcitabine.

Authors:  Askari Hasan; Akriti G Jain; Huda Naim; Alvina Munaf; George Everett
Journal:  Cureus       Date:  2018-08-02

8.  Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000.

Authors:  Alberto E Tozzi; Alfredo Caprioli; Fabio Minelli; Alessandra Gianviti; Laura De Petris; Alberto Edefonti; Giovanni Montini; Alfonso Ferretti; Tommaso De Palo; Maurizio Gaido; Gianfranco Rizzoni
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

Review 9.  Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease.

Authors:  Christa L Fischer Walker; Jennifer A Applegate; Robert E Black
Journal:  J Health Popul Nutr       Date:  2012-09       Impact factor: 2.000

10.  Hemolytic uremic syndrome incidence in New York.

Authors:  Hwa-Gan H Chang; Boldtsetseg Tserenpuntsag; Marilyn Kacica; Perry F Smith; Dale L Morse
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.